Reviva Pharmaceuticals Holdings Inc [RVPH] stock prices are up 16.39% to $0.67 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RVPH shares have gain 27.30% over the last week, with a monthly amount drifted -35.12%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Reviva Pharmaceuticals Holdings Inc [NASDAQ: RVPH] stock has seen the most recent analyst activity on September 20, 2023, when ROTH MKM initiated its Buy rating and assigned the stock a price target of $12. Previously, The Benchmark Company started tracking the stock with Speculative Buy rating on June 08, 2023, and set its price target to $17. On January 24, 2022, H.C. Wainwright initiated with a Buy rating and assigned a price target of $10 on the stock.
The stock price of Reviva Pharmaceuticals Holdings Inc [RVPH] has been fluctuating between $0.49 and $4.28 over the past year. Reviva Pharmaceuticals Holdings Inc [NASDAQ: RVPH] shares were valued at $0.67 at the most recent close of the market.
Analyzing the RVPH fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -4.38, Equity is 11.46 and Total Capital is 3.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5785 points at the first support level, and at 0.4822 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7449, and for the 2nd resistance point, it is at 0.8150.
Ratios To Look Out For
It’s worth pointing out that Reviva Pharmaceuticals Holdings Inc [NASDAQ:RVPH]’s Current Ratio is 1.01. In addition, the Quick Ratio stands at 1.01 and the Cash Ratio stands at 0.32.
